PIK3CA dependence and sensitivity to therapeutic targeting in urothelial carcinoma
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
PIK3CA dependence and sensitivity to therapeutic targeting in urothelial carcinoma ; volume:16 ; number:1 ; day:28 ; month:7 ; year:2016 ; pages:1-12 ; date:12.2016
BMC cancer ; 16, Heft 1 (28.7.2016), 1-12, 12.2016
- Urheber
-
Ross, R. L.
- Beteiligte Personen und Organisationen
-
McPherson, H. R.
Kettlewell, L.
Shnyder, S. D.
Hurst, C. D.
Alder, O.
Knowles, M. A.
SpringerLink (Online service)
- DOI
-
10.1186/s12885-016-2570-0
- URN
-
urn:nbn:de:1111-2016072950156
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:53 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Ross, R. L.
- McPherson, H. R.
- Kettlewell, L.
- Shnyder, S. D.
- Hurst, C. D.
- Alder, O.
- Knowles, M. A.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Aspirin sensitivity of PIK3CA-mutated Colorectal Cancer: potential mechanisms revisited
Carcinogenesis of PIK3CA
PIK3CA-activating mutations and chemotherapy sensitivity in stage II–III breast cancer
PIK3CA-Amplifikationen in humanen Lungenkarzinomen
PIK3CA-mutations in breast cancer
XIAP-targeting drugs re-sensitize PIK3CA-mutated colorectal cancer cells for death receptor-induced apoptosis
MiR-142-5p Suppresses Tumorigenesis by Targeting PIK3CA in Non-Small Cell Lung Cancer
Prävalenz von PIK3CA-Genmutationen beim Mammakarzinom
Comparison between urothelial and non-urothelial urethral cancer
Targeting DNA damage repair genes in cisplatin and gemcitabine resistant urothelial carcinoma cells
Multiple PIK3CA mutation clonality correlates with outcomes in taselisib + fulvestrant-treated ER+/HER2–, PIK3CA-mutated breast cancers
PIK3CA alterations in Middle Eastern ovarian cancers
Aspirin sensitivity of PIK3CA-mutated Colorectal Cancer: potential mechanisms revisited
Carcinogenesis of PIK3CA
PIK3CA-activating mutations and chemotherapy sensitivity in stage II–III breast cancer
PIK3CA-Amplifikationen in humanen Lungenkarzinomen
PIK3CA-mutations in breast cancer
XIAP-targeting drugs re-sensitize PIK3CA-mutated colorectal cancer cells for death receptor-induced apoptosis
MiR-142-5p Suppresses Tumorigenesis by Targeting PIK3CA in Non-Small Cell Lung Cancer
Prävalenz von PIK3CA-Genmutationen beim Mammakarzinom
Comparison between urothelial and non-urothelial urethral cancer
Targeting DNA damage repair genes in cisplatin and gemcitabine resistant urothelial carcinoma cells
Multiple PIK3CA mutation clonality correlates with outcomes in taselisib + fulvestrant-treated ER+/HER2–, PIK3CA-mutated breast cancers
PIK3CA alterations in Middle Eastern ovarian cancers
Aspirin sensitivity of PIK3CA-mutated Colorectal Cancer: potential mechanisms revisited
Carcinogenesis of PIK3CA
PIK3CA-activating mutations and chemotherapy sensitivity in stage II–III breast cancer
PIK3CA-Amplifikationen in humanen Lungenkarzinomen
PIK3CA-mutations in breast cancer
XIAP-targeting drugs re-sensitize PIK3CA-mutated colorectal cancer cells for death receptor-induced apoptosis
MiR-142-5p Suppresses Tumorigenesis by Targeting PIK3CA in Non-Small Cell Lung Cancer
Prävalenz von PIK3CA-Genmutationen beim Mammakarzinom
Comparison between urothelial and non-urothelial urethral cancer
Targeting DNA damage repair genes in cisplatin and gemcitabine resistant urothelial carcinoma cells
Multiple PIK3CA mutation clonality correlates with outcomes in taselisib + fulvestrant-treated ER+/HER2–, PIK3CA-mutated breast cancers